About the Editors
Editor-in-Chief
Sarah Mitchell, PhD
Princeton University
Princeton NJ USA
I am a biogerontologist with training in physiology, pharmacology, and nutritional interventions for healthy aging. I am currently a Staff Scientist in the Ludwig Cancer Princeton Branch working to understand how dietary manipulations can improve treatment efficacy in cancer, a major age-related disease. My current research focuses on implementation of metabolomics methods to develop mechanistic understanding into the aging process.
Associate Editors
Michela Borghesan, PhD
University of Groningen
Netherlands
Michela have always been fascinated by the mechanisms that explain life, particularly aging, by what we can learn from genes, and by how this knowledge can be applied to our societies from an integrated perspective. Her experience in research focus on cellular senescence, cancer and vesicles.
Dr J. Cesar Cardenas, PhD
Center for Integrative Biology, Universidad Mayor and Geroscience Center for Brain Health and Metabolism
Santiago, Chile
For the past fifteen years we have been interested in understanding how calcium communication between the endoplasmic reticulum and the mitochondria regulate cellular processes such as transcription, proliferation, autophagy, bioenergetics and cellular metabolism important for the establishment and maintenance of cellular senescence and aging.
Jose Victor Isola, PhD
Oklahoma Medical Research Foundation
United States
Dr. Jose V. Isola is a Faculty Member at the Brazilian Agricultural Research Corporation (Embrapa). He completed his PhD in Animal Health at the Federal University of Pelotas, in Brazil, where his research focused on physiology of reproduction and reproductive aging. Following his doctoral studies, Dr. Isola joined as a postdoctoral scientist at Oklahoma Medical Research Foundation (OMRF) in Oklahoma City, OK, USA where he continued studying the hallmarks of ovarian aging and the associations between anti-aging interventions and fertility. His current research focuses on investigating the role of distinct ovarian somatic cell populations on ovarian aging.
Diana Jurk, PhD
Mayo Clinic
Rochester, MN, USA
Diana Jurk is an Associate Professor of Physiology at Mayo Clinic. Her research investigates the molecular and cellular mechanisms underlying aging and age-related disorders caused by cellular dysfunction. These studies include age-related neurodegeneration such as dementia and obesity-associated disorders such as nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes. Her main research interest is the study of senescence pathways to identify novel key players and drug targets.
Juulia Jylhävä, PhD
Faculty of Medicine and Health Technology, Tampere University
Tampere, Finland
Juulia Jylhävä conducts interdisciplinary research at the intersection of frailty, biological aging, and systems biology. By integrating molecular epidemiology with advanced AI methodologies, the work of my group uncovers complex biomarkers and mechanistic pathways of aging-related decline. The team focuses on translating multi-omics data into actionable insights for precision health and risk stratification in older populations. Through this systems-level approach, they hope to advance the early detection and prevention of age-related vulnerability and chronic disease.
Hiroshi Kondoh, MD, PhD
Kyoto University
Kyoto, Japan
We investigate the metabolic mechanisms relevant to aging and aging related diseases. We mainly study novel glycolytic regulation in cancer and senescence and metabolomic analysis in human blood of age-relevant diseases.
Salvador Macip, MD, PhD
University of Leicester
Leicester, UK
Salvador Macip has been studying the pathways involved in ageing since 1998, when he joined as a postdoc the laboratory of Stuart Aaronson at Mount Sinai School of Medicine, NY. There, he contributed to define the involvement of p53, p21 and reactive oxygen species in senescence. Since 2008, he is the head of the Mechanisms of Cancer and Ageing Lab at the University of Leicester, where he has been working on defining specific markers of senescence and the development of novel senotherapies, including second generation targeted senolytics.
Larissa Prata, PhD
Cedars-Sinai Medical Center
United States
Larissa Langhi Prata is a geroscience researcher and assistant professor at Cedars Sinai. Based in Los Angeles, she explores the science of cellular senescence by day and National Parks by weekend. Brazilian-born and science-driven, she is passionate about understanding the biology of aging to help people live healthier, longer lives.
Stella Victorelli, PhD
Assistant Professor, Department of Physiology and Biomedical Engineering
Mayo Clinic
Rochester, MN, USA
My research interests involve understanding the mechanisms involved in aging and senescence. Specifically, I aim to understand the role of mitochondrial dysfunction during cellular senescence and its role in the regulation of the pro-inflammatory secretory phenotype of senescent cells. I am also interested in investigating therapeutic strategies targeting mitochondria that might translate into therapies to improve age-related diseases.
Manlio Vinciguerra, PhD
Medical University Varna
Varna, Bulgaria
Manlio Vinciguerra is an Associate Professor at the Medical University of Varna, Bulgaria; and at the LUM University, Bari, Italy. His research is focused on the role of nutrition and epigenetics in cell differentiation, senescence, and in the age-associated progression of cardio-metabolic diseases.
Emeritus Editor-in-Chief
Shin-ichiro Imai, MD, PhD
Dept. of Developmental Biology, Dept. of Medicine
Washington University School of Medicine
MO, USA
Shin-ichiro Imai is currently a Professor in the Department of Developmental Biology. Professor Imai's long-term goal is to achieve "productive aging," which aims to maintain good health and spirit in our later life, by understanding the spatial and temporal dynamics of our physiological system and developing nutriceutical/pharmaceutical interventions for age-associated complications.
Editorial Board Members
Peter Adams, PhD, The Beatson Institute, United Kingdom
Johan Auwerx, PhD, École Polytechnique Fédérale de Lausanne, Switzerland
David Bernard, PhD, Cancer Research Centre of Lyon, France
Rafael de Cabo, PhD, National Institute of Health, USA
Brian H. Chen, PhD, MPH. California Pacific Medical Center Research Institute (Sutter Health), USA
Manuel Collado, PhD, Health Research Institute of Santiago de Compostela, IDIS, Spain
Jorge Erusalimsky, PhD, Cardiff Metropolitan University, United Kingdom
Evandro Fei Fang, PhD, The University of Oslo, Oslo, Norway
Toren Finkel, PhD, National Heart, Lung and Blood Institute, NIH, USA
Vera Gorbunova, PhD,University of Rochester, NY, USA
Vassilis Gorgoulis, MD, PhD, Faculty of Medicine, National Kapodistrian University of Athens,Athens, Greece
Itamar Harel, PhD, The Silberman Institute, the Hebrew University of Jerusalem, Israel
Andrea Iaboni, MD, DPhil, University of Toronto and University Health Network, Toronto, ON, Canada
Pawel Kordowitzki, PhD, Nicolaus Copernicus University, Poland
Kenneth Langa, MD, PhD, University of Michigan, USA
Tommaso Mazza, PhD, IRCCS Casa Sollievo della Sofferenza, Rome, Italy
Mark P. Mattson, PhD, Johns Hopkins University School of Medicine, USA
Jie Mei, PhD, Nanjing Medical University, China
Tohru Minamino, PhD, Niigata University, Japan
Hong Gil Nam, PhD, Institute for Basic Science, South Korea
Satchidananda Panda, PhD, The SALK Institute, CA, USA
Gaetano Santulli, MD, PhD, Albert Einstein College of Medicine, New York, NY, USA
Hideyuki Okano, MD, PhD, Keio University, Japan
Teresa Seeman, PhD, David Geffen School of Medicine at UCLA, USA
Dorota Skowronska-Krawczyk, PhD, University of California Irvine, USA
Andrew Steptoe, PhD, University College of London, United Kingdom
Masataka Sugimoto, PhD, Tokyo Metropolitan Institute of Gerontology, Japan
Yousin Suh, PhD, Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, USA
Kazuo Tsubota, PhD, Keio University School of Medicine, Japan
Henriette van Praag, PhD, Florida Atlantic University, USA
Tatsuya Yamasoba, MD, PhD, University of Tokyo, Japan
Andrew Yoo, PhD, Washington University School of Medicine, USA
Interested in joining the journal team?
If you are interested in joining the journal as an Editorial Board Member or Associate Editor, please complete this form. Associate Editors are part of the editorial team that handle manuscripts, while Editorial Board Members are regular reviewers and are consulted for ad hoc advice. We will contact you if your expertise meets the needs of the journal.
Nature Portfolio journals are committed to promoting practices that support diversity, equity and inclusion in science communication and publishing, and we strongly encourage gender, race, ethnic, geographic, career stage and other diversity in our journal teams. Our in-house staff will use your information only for the purposes of identifying new editorial team or board members. Please contact the journal by email if you would like to remove your information from these records.
Please note that we are not able to respond to all applicants.
